Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
110.2 USD | +0.41% | -2.86% | -10.66% |
05-13 | US reclassification could drive fresh research funding into pot sector | RE |
05-07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.66% | 6.92B | |
+32.98% | 709B | |
+30.77% | 595B | |
-1.87% | 367B | |
+20.21% | 334B | |
+5.89% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.03% | 171B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- UBS Lowers Jazz Pharmaceuticals' Price Target to $182 From $194, Keeps Buy Rating